Mary T. Brophy MD

Published on 5/25/2026

Kim DY, Swetter SM, Huhmann L, Ferguson JM, Breglio K, Spence AC, Wheless L, Brophy MT, Do NV, Fillmore N, Hartman RI. Sentinel Lymph Node Biopsy Utilization and Positivity in Veterans with Cutaneous Melanoma: A Comparative Analysis of the VA Cancer Registry and the SEER Program. J Am Acad Dermatol. 2026 May 25. PMID: 42190751.

Published on 3/30/2026

Goryachev SD, Wu JT, Lin E, Friedman DR, Zwolinski R, Dhond R, Elbers DC, La J, Yildirim C, Corrigan JK, Chen DCR, Brophy MT, Do NV, Fillmore NR. Rule-based natural language processing to extract clinical trial and research study enrollment history from unstructured notes. Health Informatics J. 2026; 32(1):14604582261430614. PMID: 41912375.

Published on 2/12/2026

Hwang JC, Huhmann LB, Perez D, Kim DY, Nannini K, Do NV, Gaziano JM, Brophy MT, Wheless LE, Fillmore NR, Hartman RI. Parkinson's disease and risk of melanoma in United States veterans: A Veterans Affairs Cancer Registry retrospective cohort study. J Am Acad Dermatol. 2026 Jun; 94(6):1811-1814. PMID: 41690486.

Published on 1/2/2026

Barata PC, Corrigan JK, La J, Culnan JM, Akama-Garren E, Dulberger KN, Dumontier C, Hansen J, Bihn JR, Bitting RL, Brophy MT, Cheng HH, Cooperberg MR, Do NV, Dorff T, Fojo AT, Gaziano JM, Goryachev SD, Halabi S, Hauger RL, Nanus DM, Rebbeck TR, Pan CX, Schoen MW, Swinnerton KN, Myrie K, Ramoni RB, Fillmore NR, Paller CJ, Rettig MB. Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer. JAMA Netw Open. 2026 Jan 02; 9(1):e2551231. PMID: 41543856.

Published on 1/1/2026

Cooperberg MR, Bihn JR, Culnan JM, La J, Goryachev SD, Chen DCR, Soloviev O, Lee G, Corrigan JK, Swinnerton KN, Nickols NG, Dulberger KN, Barata P, Bitting RL, Brophy MT, Cheng HH, De Hoedt A, Do NV, Freedland SJ, Garraway IP, Gaziano JM, Halabi S, Hauger RL, Loeb S, Nanus DM, Rebbeck TR, Rettig MB, Pan CX, Myrie K, Ramoni RB, Fillmore NR, Paller CJ. Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance. JAMA Oncol. 2026 Jan 01; 12(1):111-113. PMID: 41264314.

Published on 12/14/2025

Wheeler AM, Ourada TJ, Jones SQ, Duryee MJ, England BR, Reynolds RJ, O'Dell JR, Newcomb J, Pillinger MH, Terkeltaub R, Ferguson R, Brophy M, LaMoreaux B, Merriman TR, Mikuls TR. Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapy. Rheumatology (Oxford). 2025 Dec 14. PMID: 41390970.

Published on 11/20/2025

Tosi HM, Zheng C, Tarren AH, Yellanki M, Miller SJ, Soloviev OV, Corrigan JK, Schneeloch GR, Katki HA, Kearney LE, Caverly TJ, Tanner NT, Wiener RS, Brophy M, Fillmore NR, Do NV, Elbers DC. Rapid Support and Implementation of an Application for the Prediction Augmented Screening Initiative (PASI) Planning Phase Through the Enabling Technologies for Rapid Learning Health Systems Platform (ENTHRALL) at the Department of Veterans Affairs (VA). Cancer Inform. 2025; 24:11769351251389781. PMID: 41281611.

Published on 11/20/2025

Ferri GM, Yildirim C, Do NV, Brophy MT, Munshi NC, Edwards CV, Fillmore NR. Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple Myeloma. EJHaem. 2025 Dec; 6(6):e70153. PMID: 41278511.

Published on 11/17/2025

Barry A, England BR, Sayles H, Helget LN, Androsenko M, Wu H, Michaud K, Kramer B, Newcomb JA, Brophy MT, Davis-Karim A, Ferguson R, Pillinger MH, Neogi T, Palevsky PM, O'Dell JR, Mikuls TR. Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial. Arthritis Care Res (Hoboken). 2026 Feb; 78(2):259-269. PMID: 40771143.

Published on 9/1/2025

La J, Hshieh T, Hamparsumian A, Zwolinski R, Wood J, Dharne M, Gaziano JM, Brophy MT, Do NV, Munshi NC, Driver JA, Abel GA, Fillmore NR, DuMontier C. Potentially Inappropriate Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care System. J Natl Compr Canc Netw. 2025 Sep; 23(9):363-370. PMID: 40930142.